Molecular mechanisms of choroidal neovascularization and vascular homeostasis

描述（由申请人提供）：年龄相关性黄斑变性（AMD）中的脉络膜新生血管（CNV）是全球失明的主要原因之一。我们的长期目标是阐明调节脉络膜血管发育、成人脉络膜血管稳态和CNV的分子机制。了解这些机制可能为新生血管性AMD患者提供更有针对性的治疗方法。最近的实验和临床数据为VEGF信号在CNV中的发病作用提供了强有力的证据。抗VEGF治疗在减少新生血管性AMD患者的CNV方面显示出临床益处。然而，VEGF刺激眼内CNV的分子机制知之甚少。我们提出的实验旨在全面分析VEGF和VEGF受体Flt1和Flk1对脉络膜血管功能的个体贡献，并探索这些信号通路作为治疗新生血管性AMD的新治疗方法的分子靶点。为此，我们将在小鼠中使用条件性基因靶向方法和阻断抗体治疗的组合进行实验。我们将检测VEGF、Flt1和Flk1对脉络膜内皮细胞功能的作用。此外，我们将使用已建立的CNV小鼠实验模型来研究VEGF及其受体在CNV中的作用。此外，我们将进行GFP阳性骨髓移植实验和巨噬细胞耗竭实验，以确定实验性CNV病变的细胞组成，并研究靶向VEGF信号通路的抗体对该模型中这些细胞的影响。公共卫生相关性：年龄相关性黄斑变性中的脉络膜新生血管是世界范围内致盲的主要原因之一，但对导致这种异常新生血管形成的分子机制知之甚少。本研究的目的是探讨VEGF信号在脉络膜血管系统发育、血管稳态和病理性新生血管形成中的作用。这些发现可能揭示治疗新生血管性年龄相关性黄斑变性的新分子靶点。

DESCRIPTION (provided by applicant): Choroidal neovascularization (CNV) in age-related macular degeneration (AMD) is one of the leading causes of blindness worldwide. Our long-term goal is to elucidate the molecular mechanisms that regulate choroidal vascular development, choroidal vascular homeostasis in the adult, and CNV. Understanding these mechanisms is likely to provide the basis for a more targeted therapeutic approach in patients with neovascular AMD. Recent experimental and clinical data have provided strong evidence for a pathogenetic role of VEGF signaling in CNV. Anti-VEGF treatments have shown clinical benefit in reducing CNV in patients with neovascular AMD. However, the molecular mechanisms through which VEGF stimulates CNV in the eye are only poorly understood. Our proposed experiments are directed towards a comprehensive analysis of the individual contributions of VEGF and the VEGF-receptors Flt1 and Flk1 for choroidal vascular functions, and towards exploring these signaling pathways as molecular targets for novel therapeutic approaches in the treatment of neovascular AMD. For this purpose, we will perform experiments that use a combination of conditional gene targeting approaches and treatments with blocking antibodies in mice. We will test the role of VEGF, Flt1 and Flk1 for choroidal endothelial cell functions. Furthermore, we will use an established experimental model for CNV in mice to investigate the role of VEGF and its receptors for CNV. In addition, we will perform GFP-positive bone marrow transplantation experiments and macrophage depletion experiments in order to determine the cellular composition of experimental CNV lesions and to study the effect of antibodies that target VEGF signaling pathways on these cells in this model. PUBLIC HEALTH RELEVANCE: Choroidal neovascularization in age-related macular degeneration is one of the leading causes of blindness worldwide, but only little is known about the molecular mechanisms that result in this abnormal neovascularization in the eye. The goal of the proposed studies is to investigate the role of VEGF signaling for the development, vascular homeostasis and pathological neovascularization of the choroidal vasculature. These findings are likely to reveal novel molecular targets for the treatment of neovascular age-related macular degeneration.